Pfizer invests $300m in Korean R&D
Pfizer is to plough $300m (€226m) into South Korean research and development over the next five years, while it's CEO is planning to visit North Korea tomorrow.
Archives for June 12, 2007
Melting DNA in microfluidic devices
German researchers have developed a microfluidic device that greatly increases the efficiency of measuring the melting temperature of DNA double strands.
Early birds preserve market share
Relaunching pharmaceutical products in a bid to preserve an earlier product's existing market share and maintain revenues is a common tactic in the pharma industry, but, as a recent report notes, kicking off development plans early can make all the...
Brain energy boost slows Alzheimer's
A drug that provides the brain with an alternative energy source to glucose is helping to roll back the symptoms of Alzheimer's disease.
Injectable asthma formulation uses Captisol technology
Critical Therapeutics is developing a new injectable formulation for the treatment of asthma, and is the latest company to use Captisol technology to achieve it.
Weekly comment
Corrupt Chinese drug official appeals death penalty
The former director of the country's State Food and Drug Administration (SFDA) has lodged an appeal against the death penalty slapped on him after a corruption conviction.
Solvay ups soda ash production
Solvay today announced plans to increase production of ultra-pure soda ash at it Dombasle, France, site to meet the growing demand in the pharmaceutical industry.
Lonza leans towards highly potent APIs
Lonza is building a new plant in its home country to become the only contract manufacturer with large-scale capacity for making highly potent active pharmaceutical ingredients (APIs).